









Markets
/
Stocks
/
nasdaq-enlv
/

Enlivex Therapeutics Ltd

ENLV

View Detailed Chart

1.570USD

+0.120+8.28%

Market hours （ET）Quotes delayed by 15 min

37.44MMarket Cap

LossP/E TTM



Enlivex Therapeutics Ltd

1.570

+0.120+8.28%

Overview Company Financials

Financials

Intraday

30m

Today

+8.28%

5 Days

+39.93%

1 Month

+33.05%

6 Months

+45.37%

Year to Date

+34.19%

1 Year

+17.16%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

BUY

Current Rating

10.000

Target Price

589.66%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

Enlivex Therapeutics Ltd

ENLV

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(2)

Buy(9)

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.051

Buy

RSI(14)

65.989

Neutral

STOCH(KDJ)(9,3,3)

65.680

Neutral

ATR(14)

0.108

High Vlolatility

CCI(14)

106.291

Buy

Williams %R

38.798

Buy

TRIX(12,20)

0.723

Sell

StochRSI(14)

38.316

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

1.432

Buy

MA10

1.296

Buy

MA20

1.270

Buy

MA50

1.126

Buy

MA100

1.066

Buy

MA200

1.129

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Ticker SymbolENLV

CompanyEnlivex Therapeutics Ltd

CEODr. Oren Hershkovitz, Ph.D.

Websitehttps://www.enlivex.com/